AXIM BIOTECHNOLOGIES, INC. (AXIM) Shareholders’ equity 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) shareholders’ equity at each fiscal year-end, per SEC filings.
-$7.7MFY2023 · since FY2015: -$1.7M → -$7.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$7.7M | -24.3% |
| FY2022 | -$6.2M | -163.5% |
| FY2021 | -$2.3M | -249.3% |
| FY2020 | $1.6M | +123.2% |
| FY2019 | -$6.8M | -11.2% |
| FY2018 | -$6.1M | +3.2% |
| FY2017 | -$6.3M | -165.0% |
| FY2016 | -$2.4M | -39.9% |
| FY2015 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice